PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25766325-0	2015	A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells.	benzimidazole	2-15	erb-b2 receptor tyrosine kinase 2	Homo sapiens	73-77	
32955008-0	2021	Repurposing of Benzimidazole Scaffolds for HER-2 Positive Breast Cancer Therapy: An In-Silico Approach.	benzimidazole	15-28	erb-b2 receptor tyrosine kinase 2	Homo sapiens	43-48	
25844392-10	2014	The benzimidazole microtubule/tubulin inhibitor, mebendazole complemented the anti-neoplastic cytotoxicity of gemcitabine-(C4-amide)-[anti-EGFR] in dual-combination with epirubicin-(C3-amide)-[anti-HER2/neu].	benzimidazole	4-17	erb-b2 receptor tyrosine kinase 2	Homo sapiens	198-202	
25844392-12	2014	The benzimidazole tubulin/microtubule inhibitor, mebendazole also possessed anti-neoplastic cytotoxicity against chemotherapeutic-resistant mammary adenocarcinoma (SKBr-3) and complemented the potency and efficacy of gemcitabine-(C4-amide)-[anti-EGFR] in dual-combination with epirubicin-(C3-amide)-[anti-HER2/neu].	benzimidazole	4-17	erb-b2 receptor tyrosine kinase 2	Homo sapiens	305-309	
27987485-0	2017	Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors.	benzimidazole	57-70	erb-b2 receptor tyrosine kinase 2	Homo sapiens	119-124	
27987485-1	2017	The synthesis of benzimidazole linked oxadiazole derivatives designed as potential EGFR and erbB2 receptor inhibitors with anticancer and apoptotic activity were studied.	benzimidazole	17-30	erb-b2 receptor tyrosine kinase 2	Homo sapiens	92-97